Literature DB >> 1854165

Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters.

J Blaser1, H L Rieder, R Lüthy.   

Abstract

Human pharmacokinetics of netilmicin during multiple dosing were studied in serum and in the fluid of skin blisters with two different ratios of interface area to fluid volume. The kinetics in the blisters followed the serum concentration-time curve with a delay but with a similar elimination half-life of 2.4 h. The kinetics in the 40-microliters blisters followed closely the theoretically calculated concentrations of the peripheral compartment of a two-compartment model. In contrast, the concentrations in the 120-microliter blisters increased less rapidly, lower peaks were achieved, and concentrations decreased with a significantly longer delay. A very similar area-specific flow or clearance rate of 1.6 microliters.h-1.mm-2 was calculated for the interface area between the serum compartment and either the small or large blisters. The observed rapid mass transfer between serum and blister fluid suggests similar oscillations of concentrations in serum and in small interstitial fluid compartments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854165      PMCID: PMC245116          DOI: 10.1128/AAC.35.5.837

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Influence of surface area/volume ratio on the kinetics of antibiotics in different tissues and tissue fluids.

Authors:  D M Ryan
Journal:  Scand J Infect Dis Suppl       Date:  1985

2.  Suction blister device for separation of viable epidermis from dermis.

Authors:  U Kiistala
Journal:  J Invest Dermatol       Date:  1968-02       Impact factor: 8.551

3.  Biological variability of multiple dose pharmacokinetics of netilmicin in man.

Authors:  J Blaser; H Rieder; P Niederer; R Lüthy
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model.

Authors:  L L Van Etta; L R Peterson; C E Fasching; D N Gerding
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

5.  Increase of amikacin half-life during therapy in patients with renal insufficiency.

Authors:  J Blaser; S Rüttimann; H Bhend; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

6.  Multicompartment pharmacokinetics of netilmicin.

Authors:  M Wenk; P Spring; S Vozeh; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

7.  Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives.

Authors:  P M Tulkens
Journal:  Am J Med       Date:  1986-06-30       Impact factor: 4.965

  7 in total
  11 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Stephanie H Kim; Karl G Csaky; Nam Sun Wang; Robert J Lutz
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

Review 4.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.

Authors:  D M Cappelletty
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

6.  Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling.

Authors:  M Brunner; A Schmiedberger; R Schmid; D Jäger; E Piegler; H G Eichler; M Müller
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

7.  Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method.

Authors:  M Manduru; L B Mihm; R L White; L V Friedrich; P A Flume; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

8.  Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection.

Authors:  Charles R Bonapace; Lawrence V Friedrich; John A Bosso; Roger L White
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

9.  Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.

Authors:  Lucy Sasongko; Kenneth M Williams; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

10.  Enhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients.

Authors:  Julia K Mader; Thomas Birngruber; Stefan Korsatko; Sigrid Deller; Gerd Köhler; Susanne Boysen; Thomas Augustin; Selma I Mautner; Frank Sinner; Thomas R Pieber
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.